Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,130.00    -4.00 (-0.10%)
Bid:
4,122.00
Ask:
4,130.00
Spread: 8.00 (0.194%)
Market Cap: £4.33b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Pre-Close Trading Update

10 Jul 2008 07:00

RNS Number : 7434Y
Computacenter PLC
10 July 2008
 



Computacenter plc

Pre-Close Trading Update

Computacenter is today holding an Investor and Analyst conference call to provide an update on trading for the six months to 30 June 2008.

Group revenues for the first-half of 2008 will show growth of approximately 8%. Even after taking into consideration the benefit of a strengthening euro, the organic growth rate is the strongest for a number of years. 

Since we last reported on trading, the improved performance at our UK and French subsidiaries has continued. We are pleased to report that the Q2 2008 performance was ahead of Q1 2008, and ahead of Q2 2007 in both revenue and profit in both countries.

As we have already announced, the UK had a difficult start to 2008 and the first six weeks trading was particularly tough, however UK sales for the first six months were up 4.8% and up 8.3% in Q2. We have seen strong growth from our Software Business Unit where we believe we have gained significant market share however this does have a diluting effect on our overall gross margins.

We continue to invest heavily in our UK business to build our position in the mid-market and to increase our services capability. These investments, together with the poor start to the year will, as anticipated, result in UK first-half profitability below last year.

The improved performance in France in Q2 has meant that the first half loss will be broadly similar to H1 2007 in local currency but the positive trend in performance together with some major contract successes bodes well for the second half of 2008.

In Germany trading has been consistent throughout the first half of 2008. Revenue in local currency has fallen slightly in comparison to the first-half of 2007, however, mainly due to improved services margins, the profit growth we experienced last year has continued. 

Group debt at the end of the period will be approx £30M (2007H1: £16.5M) before customer specific financing. Good cash generation meant that before taking into account the £20.8M we have spent buying back shares since 1 July 2007 our net debt position improved by £7.3M.

We are encouraged by the Group's performance in the second quarter. Although there is much uncertainty in the market place, customers undoubtedly need to invest in information technology to increase the efficiency of their businesses, reduce risk and improve their competitiveness. We believe customers are increasingly looking to Computacenter to gain an increased value from their information technology investment.

As anticipated first-half Group pre-tax profits are expected to be lower than the same period last year. However, due to the impact of share buy backs and an improved tax position, earnings per share will show aimprovement.

Computacenter will report its Interim results on 28 August 2008.

Enquiries:

 

Computacenter plc
 
Mike Norris, Chief Executive
01707 631601
Tony Conophy, Finance Director
01707 631515
Tessa Freeman, PR Manager
01707 631514
 
 
Tulchan Communications
020 7353 4200
Andrew Grant
 
Stephen Malthouse
 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFGGGNNLZGRZM
Date   Source Headline
2nd Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSQ3 2022 Trading Update
20th Oct 202210:30 amRNSDirectorate Change
27th Sep 202212:00 pmRNSHolding(s) in Company
22nd Sep 202210:30 amRNSDirector/PDMR Shareholding
12th Sep 202212:00 pmRNSDirector/PDMR Shareholding
9th Sep 20227:00 amRNSHalf-year Report
5th Aug 20229:30 amRNSBlock listing Interim Review
13th Jul 20227:00 amRNSAcquisition
19th May 20221:30 pmRNSResult of AGM
9th May 20225:30 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSQ1 2022 Trading Update
27th Apr 20229:03 amRNSCarbon Neutral Announcement
13th Apr 202212:15 pmRNS2021 Annual Financial Report & Notice of 2022 AGM
23rd Mar 20224:45 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSFinal Results 2021
7th Feb 20229:49 amRNSBlock listing Interim Review
24th Jan 20227:00 amRNSPre-Close Trading Statement
12th Jan 20229:45 amRNSHolding(s) in Company
14th Dec 20214:45 pmRNSHolding(s) in Company
13th Dec 20215:00 pmRNSHolding(s) in Company
10th Dec 20212:00 pmRNSCompany Secretary Change
2nd Dec 20212:45 pmRNSDirector/PDMR Shareholding
15th Nov 202112:15 pmRNSDirector/PDMR Shareholding
29th Oct 20217:00 amRNSQ3 2021 Trading Update
30th Sep 202112:00 pmRNSDirectorate Change
15th Sep 20214:25 pmRNSDirector/PDMR Shareholding
9th Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSTrading Statement
12th Aug 202112:00 pmRNSDirector Declaration
6th Aug 202111:15 amRNSBlock listing Interim Review
21st Jul 20217:00 amRNSTrading Statement
20th May 20211:00 pmRNSResult of AGM
30th Apr 20217:00 amRNSDirector/PDMR Shareholding
29th Apr 20217:00 amRNSQ1 2021 Trading Update
20th Apr 20217:00 amRNS2020 Annual Report & Notice of 2021 AGM
24th Mar 20212:00 pmRNSDirector/PDMR Shareholding
16th Mar 20217:00 amRNSFinal Results 2020
10th Mar 20217:00 amRNSDirectorate Change
5th Feb 20211:18 pmRNSBlock listing Interim Review
25th Jan 202111:45 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSPre-Close Trading Statement
4th Jan 20211:00 pmRNSDirector/PDMR Shareholding
10th Dec 20207:00 amRNSTrading Statement
10th Nov 20204:00 pmRNSPDMR/PCA Shareholding
30th Oct 20207:00 amRNSQ3 2020 Trading Update
27th Oct 20209:30 amRNSDirector/PDMR Shareholding
23rd Oct 20205:45 pmRNSApproval of Arrangement Agreement
16th Sep 202012:45 pmRNSDirector/PDMR Shareholding
15th Sep 20201:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.